ArticleJournal of thoracic disease2023

High level of C-reactive protein as a predictive factor for immune-related adverse events of immune checkpoint inhibitors in non-small cell lung cancer: a retrospective study.

Ren Onodera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.